FCM
CDNA icon

Flinton Capital Management’s CareDx CDNA Stock Holding History

Flinton Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$9K Buy
+384
New +$10.6K ﹤0.01% 885

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Flinton Capital Management's CDNA Position: Q3 2019 in Review

Flinton Capital Management opened a new position in CareDx (CDNA) in Q3 2019: 384 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #885 among its holdings.

174 funds tracked by Wall St. Rank hold CDNA as of Q3 2019.

  • Flinton Capital Management held 384 shares of CareDx worth $9K as of Q3 2019.
  • CareDx was a new Flinton Capital Management position in Q3 2019.
  • CareDx made up ﹤0.01% of Flinton Capital Management's portfolio in Q3 2019, its #885 holding.
  • 174 funds tracked by Wall St. Rank held CareDx as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.